Thyora Therapeutics develops precision covalent inhibitors for cancers and immune disorders, leveraging novel covalent warheads and a proprietary chemoproteomic platform to enable late-stage functionalization and discover previously undruggable targets.
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
